Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 19,098 shares at $42.80 ($817K) on 2025-08-04, disclosed to the SEC on 2025-08-05.
Scheduled sale ($817k) by EVP, Chf Clinical Develop Ofcr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.80 | 9,549 | $409K | 50.0% |
| 2 | $42.80 | 9,549 | $409K | 50.0% |
| Total | $42.80 avg | 19,098 | $817K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |